CN118555958A - 含有来自金线吊乌龟的生物碱的制剂 - Google Patents

含有来自金线吊乌龟的生物碱的制剂 Download PDF

Info

Publication number
CN118555958A
CN118555958A CN202280075587.5A CN202280075587A CN118555958A CN 118555958 A CN118555958 A CN 118555958A CN 202280075587 A CN202280075587 A CN 202280075587A CN 118555958 A CN118555958 A CN 118555958A
Authority
CN
China
Prior art keywords
novel coronavirus
stephanine
results
preparation containing
alkaloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280075587.5A
Other languages
English (en)
Chinese (zh)
Inventor
渡士幸一
佐宗若奈
寺岛徹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sawai Pharmaceutical Co Ltd
National Institute of Infectious Diseases
Original Assignee
Sawai Pharmaceutical Co Ltd
National Institute of Infectious Diseases
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sawai Pharmaceutical Co Ltd, National Institute of Infectious Diseases filed Critical Sawai Pharmaceutical Co Ltd
Publication of CN118555958A publication Critical patent/CN118555958A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CN202280075587.5A 2021-11-17 2022-07-04 含有来自金线吊乌龟的生物碱的制剂 Pending CN118555958A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021186784 2021-11-17
JP2021-186784 2021-11-17
PCT/JP2022/026543 WO2023089862A1 (ja) 2021-11-17 2022-07-04 タマサキツヅラフジ由来アルカロイド含有製剤

Publications (1)

Publication Number Publication Date
CN118555958A true CN118555958A (zh) 2024-08-27

Family

ID=86396581

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280075587.5A Pending CN118555958A (zh) 2021-11-17 2022-07-04 含有来自金线吊乌龟的生物碱的制剂

Country Status (6)

Country Link
US (1) US20240299481A1 (https=)
EP (1) EP4434521A4 (https=)
JP (1) JP7804878B2 (https=)
CN (1) CN118555958A (https=)
TW (1) TW202320775A (https=)
WO (1) WO2023089862A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116253740A (zh) * 2021-12-10 2023-06-13 中国科学院上海药物研究所 环状双苄基异喹啉类化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12022553084A1 (en) * 2020-05-14 2024-03-25 Kowa Co Novel inhalant

Also Published As

Publication number Publication date
US20240299481A1 (en) 2024-09-12
JP7804878B2 (ja) 2026-01-23
EP4434521A1 (en) 2024-09-25
JPWO2023089862A1 (https=) 2023-05-25
TW202320775A (zh) 2023-06-01
WO2023089862A1 (ja) 2023-05-25
EP4434521A4 (en) 2025-11-05

Similar Documents

Publication Publication Date Title
Faisal et al. Alkaloids as potential antivirals. A comprehensive review
EP2424552B1 (en) Ganoderma lucidum extracts for treating parkinson's disease
TWI907588B (zh) 草藥組成物、其製備方法及將其投藥用於預防或治療病毒感染的方法
CN114306338B (zh) 双四氢异喹啉类化合物在制备用于预防和/或治疗冠状病毒感染的药物中的应用
CN111467363A (zh) 索非布韦在制备预防和治疗冠状病毒的药物中的应用
WO2020259706A1 (zh) 氨来占诺用于制备抗肝炎病毒药物的用途
EP4387733A1 (en) Inhibitors for coronavirus
US20240299481A1 (en) Stephania cepharantha-derived alkaloid-containing preparation
WO2021203706A1 (zh) 膦甲酸钠在制备预防和治疗冠状病毒的药物中的应用
JPWO2023089862A5 (https=)
CN112263671A (zh) 一种可有效抑制HIV、HBV、H1N1、H3N2和nCoV的复合制剂
CN106038695A (zh) 鳄梨萃取物、鳄梨醇b及(2r,4r)-1,2,4-三羟基十七碳-16-炔的用途，以及包含鳄梨萃取物的保健食品
CN107468682A (zh) 芒果苷在制备抗病毒药物中的应用
CN111317752B (zh) 一种预防或治疗流感病毒感染的药物及用途
CN113440527B (zh) 萘酚喹或含萘酚喹的组合制剂在抗冠状病毒中的应用
US10864210B2 (en) Composition and combined medication method for treating enterovirus infection
CN113908160A (zh) 小檗胺在抗结核分枝杆菌药物中的应用
CN103565970B (zh) 一种治疗艾滋病的地榆提取物及其制备方法
Chen Pharmacology of Chinese materia medica
CN110314166B (zh) 牛磺熊去氧胆酸在抗手足口病毒和水泡口炎病毒药物中的应用
Manap Pharmacological effect of agarwood essential oil (AEO) extract as anti-viral agent against hepatitis B virus
TW202339783A (zh) 一種草藥萃取物用於製備抑制一個體感染新型冠狀病毒的醫藥組合物之用途
JP2025094278A (ja) アレルギー性鼻炎及び／又は副鼻腔炎症状改善用組成物
CN119174773A (zh) 一种抗病毒组合物及其制备方法和应用
HK40082238B (zh) 草药组合物、其制备方法及将其施用以用於预防或治疗病毒感染的方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination